Metals against cancer: Univ:view interview with Bernhard Keppler


"Metalle als Feinde des Tumors": Forschungsnewsletter Universität Wien Oktober 2019

Bernhard Keppler talks to Uni:view about the progress ofmetal-based anticancer drugs, the latest development of KP46 and KP1339, the new compound Albuplatin and P4 Therapeutics, the joint reasearch cluster with the Medical University of Vienna and the importance of translational research.